Procter & Gamble stock softens as analysts flag earnings risks

Published on 09/10/2026 at 14:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Procter & Gamble stock closed at USD 142.64 on September 9, 2026, down 2.02 percent from the prior day. Analysts see EPS for Q1 2027 slipping about 5 percent year over year even as full-year revenue is expected to grow modestly.

Extremes Makrofoto von irisierenden Seifenblasen und weißem Waschmittelschaum mit Regenbogenreflexen — Procter Kernkompetenz Reinigung US7427181091 in extremer Makro Aufnahme von schillernden irisierenden Seifenschaum Blasen, Illustration mit AI erstellt.

Procter & Gamble stock (ISIN US7427181091) closed at USD 142.64 on the New York Stock Exchange on September 9, 2026, marking a 2.02 percent decline from the prior session and signaling a cautious tone ahead of the next earnings release.

Recent price move and trading context

According to a performance review by Yahoo Finance on September 9, 2026, Procter & Gamble finished that trading session at USD 142.64, a 2.02 percent drop compared with the prior close as the shares underperformed the broader market.

Intraday data compiled by Robinhood show that on September 10, 2026, the stock traded between USD 142.28 and USD 145.15, with an intraday quote of USD 142.64 giving the company a market capitalization of about USD 331.38 billion at that point.

That market capitalization level leaves the stock meaningfully below the consensus analyst price target of USD 161.19, implying roughly 13 percent potential upside if the shares were to move in line with the average target cited in recent coverage.

Earnings trajectory and upcoming Q1 2027 report

Investors are now focused on the next quarterly update, with the earnings calendar on Markets Insider listing the upcoming Q1 2027 earnings release for Procter & Gamble on October 22, 2026.

As highlighted by Yahoo Finance on September 9, 2026, consensus estimates point to earnings per share of USD 1.89 for that upcoming quarter, which would represent a 5.03 percent decline compared with the prior-year quarter.

The same consensus overview cited by Yahoo Finance indicates that Procter & Gamble is expected to report quarterly revenue of USD 22.68 billion for the Q1 2027 period, up 1.33 percent from the year-ago quarter, suggesting that modest top-line growth may be accompanied by margin pressure.

Looking at the broader fiscal year 2027, the Zacks Consensus Estimates referenced by Yahoo Finance project full-year earnings of USD 6.99 per share and revenue of USD 88.63 billion, increases of 1.45 percent and 1.84 percent respectively versus the prior fiscal year.

Recent reported results and profitability metrics

For context, Procter & Gamble has already reported its fiscal 2026 results, with the Q4 2026 earnings release dated July 29, 2026 showing earnings per share of USD 1.26 for that quarter as documented in the earnings history on Markets Insider.

The same earnings overview from Markets Insider lists EPS figures of USD 1.63 for Q3 2026, USD 1.78 for Q2 2026 and USD 1.95 for Q1 2026, illustrating a relatively stable profitability profile over the past fiscal year.

Complementing those discrete quarterly figures, a fundamentals snapshot from Pluang on September 9, 2026 notes that Procter & Gamble generated revenue of roughly USD 84.28 billion over its most recently reported fiscal year, with a net income margin of 18.44 percent and a return on equity of 30.13 percent.

These profitability metrics, taken together with the consensus forecast for fiscal 2027 revenue growth of 1.84 percent, suggest that the company is expected to continue delivering high returns on equity while only modestly expanding its top line.

Analyst views, price targets and valuation

On the valuation front, the same Pluang data snapshot dated September 9, 2026 indicates that Procter & Gamble trades at a price-to-earnings ratio of about 21.99 based on its most recent earnings, placing the shares at a premium to many defensive consumer staples peers but supported by the company's strong brands and cash generation.

Analyst sentiment remains constructive but not euphoric, with multiple MarketBeat alerts in September 2026 summarizing that thirteen research analysts currently rate Procter & Gamble stock as a Buy and eleven assign a Hold rating, resulting in a consensus rating described as Moderate Buy along with an average price target around USD 161.19 as reported by MarketBeat on September 10, 2026.

Within that broader consensus, individual houses have taken nuanced positions; for example, Sanford C. Bernstein reiterated a Market Perform rating with a USD 149.00 price target in a research note referenced by MarketBeat on September 10, 2026.

Comparing the USD 149.00 Bernstein target with the consensus level of USD 161.19, the more cautious stance from Bernstein sits about 7.6 percent below the average target, which may reflect their view that valuation already prices in much of the expected earnings resilience.

For investors, the spread between the current trading level around USD 142 to USD 145 and these targets underscores that the market is weighing modest upside potential against forecast earnings softness in the near term.

Risks around margins, input costs and growth

The earnings estimates pointing to a 5.03 percent year-over-year decline in EPS for Q1 2027, even as revenue is projected to grow by 1.33 percent, highlight that margin dynamics are central to the Procter & Gamble investment case in the coming quarters.

Commentary in the September 9, 2026 overview from Yahoo Finance notes that investors are likely to watch how the company manages input cost pressures and promotional spending in order to support margins while preserving market share.

At the same time, the full-year revenue growth estimate of 1.84 percent from the Zacks Consensus suggests that Procter & Gamble is not expected to deliver rapid expansion, so earnings performance will hinge on efficiency gains and pricing rather than volume-driven growth.

In this environment, the company's historically strong net income margin of 18.44 percent and high return on equity of 30.13 percent, as cited by Pluang, become key metrics that investors will monitor closely for signs of sustained quality or emerging pressure.

Dividend profile and long-term positioning

Procter & Gamble's appeal for many shareholders extends beyond near-term earnings, with Markets Insider data showing an annual dividend of USD 4.26 per share in 2026 and a dividend yield of about 2.90 percent, underlining the stock's role as an income-generating holding in many portfolios.

As the company moves toward its October 22, 2026 Q1 2027 earnings release, attention is likely to focus on whether management signals any adjustments to payout policy or capital allocation priorities in response to evolving macroeconomic conditions and competitive dynamics.

The consensus Moderate Buy rating and the average price target of USD 161.19, however, indicate that the analyst community broadly expects Procter & Gamble to navigate these challenges while maintaining its long-standing reputation for steady dividends and disciplined brand investment.

Stock level ahead of the next earnings date

As of September 9, 2026, the reference closing price for Procter & Gamble stock on its primary listing venue, the New York Stock Exchange, stood at USD 142.64, providing a clear benchmark for investors as they track movements in the run-up to the Q1 2027 earnings report scheduled for October 22, 2026.